Dr. Hasan, whose company is called Surgimatix, devised the wound-closure device during his residency at University of Michigan Hospital and Health Centers.
Initial funding for Surgimatix came from the Frankel Commercialization Fund, an early-stage investment fund linked with the University of Michigan. In June 2010, Surgimatix completed pre-clinical testing that showed superior performance of the technology over traditional sutures.
Related Articles on Surgical Supplies:
Physician Office Manager Pleads Guilty to Buying Unapproved Devices
7 Ways to Slash Costs of Surgical Supplies
Amerinet, Cardinal Health Sign Agreements for Medical-Surgical and Pharmaceutical Supplies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
